As a biochemist, I started my career in biomedical research, but I shifted to agricultural research in 2013 because everybody needs to eat. Now I'm ...
News
- Helping plants remove natural toxins could boost crop yields by 47 percent
- Global stocks sink on trade worries, oil mixed
... said the initiatives were aimed at preventing Beijing from moving ahead with plans to develop global competitors in technologies including biotech ...
- Initial public offerings scheduled to debut next week
Business: Early-stage biotech developing mRNA therapies for genetic ... Business: Late-stage biotech targeting conditions associated with chronic ...
- SA researchers exploring use of re-purposed cancer drugs to combat deadly TB
Scientists at San Antonio's Texas Biomedical Research Institute are studying the effectiveness of promising experimental cancer chemotherapy drugs ...
- Assembly Biosciences (Call) (ASMB) Valuation Declined While Longwood Capital Partners ...
Assembly Biosciences, Inc. (NASDAQ:ASMB) has risen 70.43% since June 22, 2017 and is uptrending. It has outperformed by 57.86% the S&P500.